Helix Biopharma Corp.
HBPCF
$0.60
$0.011.70%
OTC PK
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 0.15% | 1,437.46% | -86.15% | 27.40% | -47.32% |
| Total Receivables | -63.75% | -50.84% | -48.09% | -16.99% | -23.90% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -18.97% | 53.07% | -3.09% | 142.59% | 188.59% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -10.30% | 574.33% | -78.28% | 39.21% | -29.32% |
|
|
|||||
| Total Current Assets | -10.30% | 574.33% | -78.28% | 39.21% | -29.32% |
| Net Property, Plant & Equipment | -79.35% | -53.87% | -77.97% | -7.57% | -6.79% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -12.35% | 502.53% | -78.22% | 37.79% | -28.76% |
|
|
|||||
| Total Accounts Payable | 62.60% | 921.25% | 0.07% | 65.15% | 175.10% |
| Total Accrued Expenses | 68.11% | 183.23% | 172.42% | 79.98% | 27.26% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 58.55% | 246.62% | 39.20% | -19.77% | 120.32% |
|
|
|||||
| Total Current Liabilities | 58.55% | 246.62% | 39.20% | -19.77% | 120.32% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 58.55% | 246.62% | 39.20% | -19.77% | 120.63% |
|
|
|||||
| Common Stock & APIC | 2.97% | -3.98% | 2.58% | -0.05% | 3.09% |
| Retained Earnings | -4.08% | 3.10% | -4.26% | 0.39% | -1.71% |
| Treasury Stock & Other | 53.70% | 77.55% | 40.51% | 1.61% | -61.04% |
| Total Common Equity | -284.08% | 93.23% | -318.58% | 89.85% | -138.90% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -284.08% | 93.23% | -318.58% | 89.85% | -138.90% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -284.08% | 93.23% | -318.58% | 89.85% | -138.90% |
|
|
|||||